Browse studies

Find your next paid study

27,428 recruiting studies available now

Open-label, Phase 1, Multi-Center Master Protocol to Evaluate the Safety and Preliminary Anti-Tumor Activity of TCR-engineered T Cells Recognizing KRAS Mutations in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors

Phase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metasta…

Non-small Cell Lung CancerColorectal CarcinomaPancreatic Ductal Adenocarcinoma+3 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT06218914

Observational

A Phase I/II Study of Disappearing Markers for Daily Radiation Treatment Delivery

The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radia…

Ductal Carcinoma in SituStage I Breast CancerStage II Breast Cancer+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Barbara Ann Karmanos Cancer InstituteNCT07095114

Phase 2

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma and Castration-resistant Prostate Cancer

To learn if ivonescimab can help to control advanced cSCC. The safety and effects of ivonescimab will also be studied.

Cutaneous Squamous Cell Carcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06567314

Study to Use Change in Near Infrared Spectroscopy Assessment of Tissue Oxygenation During a Provocative Leg Maneuver to Assess Peripheral Artery Disease State.

The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during…

Peripheral Arterial Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Kent Imaging IncNCT06237621

Phase 2

An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With Heart Failure and Implantable Cardioverter-Defibrillators

This is a Phase 2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for quantification of myocardial sympathetic innervat…

Heart FailureIschemic CardiomyopathyICD Patients

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)NCT06965621

Phase 2

A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With Persistent Corneal Epithelial Defects (NEXPEDE-1)

This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCE…

Persistent Corneal Epithelial Defect

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Glaukos CorporationNCT05966493

Phase 1

A Phase 1/2 Study of M3814 (Peposertib) in Combination With Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

This phase I/II trial studies the safety, side effects and best dose of M3814 and to see how well it works when given together with radiation therapy in treati…

Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04172532

Observational

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supporti…

End of LifeCancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT05297734

Phase 3

Phase III Study to Compare the Effectiveness of Magnetic Resonance Guided Focused Ultrasound With Computed Tomography Guided Radiofrequency Ablation for Treatment of Osteoid Osteomas

Osteoid osteomas are painful, benign bone tumors that occur most frequently in young males between ages 10 and 20 years. The goal of the proposed study is base…

Osteoid Osteoma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Matthew BucknorNCT02923011

Phase 2

Mechanisms for Activation of Beige Adipose Tissue in Humans

Mirabegron (Myrbetriq®, Astellas) is a highly specific and well-tolerated ß3 agonist marketed for overactive bladder. This trial will assess the effects of mir…

PreDiabetes

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Philip KernNCT04666636

Study of Oral Food Challenge Biomarkers (CoFAR-15)

This is a multi-center, mechanistic study. It is designed to learn more about signs in the body, called biomarkers, that might show if someone will have a reac…

Allergy

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT07279467

Observational

Cognitive Biomarkers in Pediatric Brain Tumor Patients

The investigators will focus on three cohorts of brain tumor patients aged, 4-18 years, to answer two critical questions: 1) Can the investigators acquire high…

Childhood Brain Tumor

Estimated

~$10 – $750

Actual pay is set by the research site.

Washington University School of MedicineNCT02914067